Trial
NCT00078806
Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Amgen
Collaborators
Immunex Corporation
Condition
Juvenile Rheumatoid Arthritis
Intervention
Etanercept
Why stopped
the study was terminated because of slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-25